| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/30/1998 | CA2278123A1 Use of fxr, ppar.alpha. and lxr.alpha. activators to restore barrier function, promote epidermal differentiation and inhibit proliferation |
| 07/30/1998 | CA2277166A1 Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimidazole, and optionally a potentiator |
| 07/30/1998 | CA2228017A1 A drug preparation for oral administration |
| 07/29/1998 | EP0855444A2 Aspartic proteinase 2 (ASP2) |
| 07/29/1998 | EP0855392A2 Five-membered heterocycles having biphenylsulphonyl substituents, processes for the preparation thereof, their use as medicaments or diagnostic agent and medicaments containing them |
| 07/29/1998 | EP0855389A2 A 3,7-dithiaprostanoic acid derivative |
| 07/29/1998 | EP0855182A1 3-Deoxyglucosone production inhibitor |
| 07/29/1998 | EP0854927A1 Human dnase i variants |
| 07/29/1998 | EP0854884A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor |
| 07/29/1998 | EP0854870A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 07/29/1998 | EP0854863A1 Esters and amides as pla2 inhibitors |
| 07/29/1998 | EP0854722A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 07/29/1998 | EP0854721A1 Endothelin receptor antagonists |
| 07/29/1998 | EP0854717A1 Use of 5ht 1b? receptor antagonist for the treatment of vascular disease |
| 07/29/1998 | EP0854715A1 Methods of inhibiting plasminogen activator inhibitor 1 |
| 07/29/1998 | EP0854714A1 Substituted indolylpropyl-piperazine derivatives as 5-ht 1dalpha? agonists |
| 07/29/1998 | EP0854711A1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 07/29/1998 | EP0854710A2 USE OF A $g(g)-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 07/29/1998 | EP0794949B1 Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs |
| 07/29/1998 | EP0740668B1 Tetracyclic derivatives, process of preparation and use |
| 07/29/1998 | EP0681571B1 Spiro-substituted azacycles as tachykinin receptor antagonists |
| 07/29/1998 | CN1189166A Somatostatin peptides |
| 07/29/1998 | CN1188766A New ellipticine achroalkali compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/29/1998 | CN1188760A Benzidine-sulfuryl radical substitution pentatomic heterocycle, its preparation method, its medicinal and composition |
| 07/29/1998 | CN1188670A Medicine mixed type cigarette and producing method thereof |
| 07/29/1998 | CN1188645A Process for preparing pharmaceutical composition for treatment or prevention hypertension |
| 07/29/1998 | CN1039327C Novel thio-substituted nitrogen-containing heterocyclic phosphonate compounds, pharmaceutical compositions and pharmacy application |
| 07/29/1998 | CN1039322C Preparation method of indole derivatives |
| 07/29/1998 | CN1039320C Method for preparing cyclohexane and octahydro-benzo (f) quinolinones and its optical isomer |
| 07/29/1998 | CN1039317C Substituted benzoate derivatives |
| 07/28/1998 | US5786449 Streptogramin derivatives, their preparation and pharmaceutical compositions which contain them |
| 07/28/1998 | US5786372 Heteroaryl compounds used as pharmaceuticals |
| 07/28/1998 | US5786368 Inhibitors of glycolipids |
| 07/28/1998 | US5786365 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith |
| 07/28/1998 | US5786364 Nervous system disorders; psychological disorders; drug abruse |
| 07/28/1998 | US5786358 Inhibitors of glycinamide ribonucleotide formyl transferase |
| 07/28/1998 | US5786356 Selective β3 adrenergic agonists |
| 07/28/1998 | US5786354 Tri-substituted phenyl derivatives and processes for their preparation |
| 07/28/1998 | US5786347 Vitamin D amine and amide derivatives |
| 07/28/1998 | US5786336 Granulocyte macrophage progenitor stimulants, tripeptides |
| 07/28/1998 | US5786330 Polypeptides as anticoagulants |
| 07/28/1998 | US5786327 Polypeptides for bone disorders |
| 07/28/1998 | US5786197 lep |
| 07/28/1998 | US5786158 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/28/1998 | US5786157 DNA encoding human 5-HT1D receptors and uses thereof |
| 07/28/1998 | US5785993 Reduction of adhesions using controlled delivery of active oxygen inhibitors |
| 07/28/1998 | CA2221686A1 Asp2 |
| 07/28/1998 | CA2141563C Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 07/28/1998 | CA2105072C Morphinan derivative and its pharmaceutical applications |
| 07/28/1998 | CA2082527C Use of purine derivatives for anesthesia, analgesia and in vivo organ preservation |
| 07/23/1998 | WO1998032022A1 Growth factor-dependent diseases |
| 07/23/1998 | WO1998032017A2 Modulators of insulin receptor activity |
| 07/23/1998 | WO1998031803A1 Therapies involving mutated heat shock transcription factor |
| 07/23/1998 | WO1998031802A2 Secreted proteins and polynucleotides encoding them |
| 07/23/1998 | WO1998031801A1 I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis |
| 07/23/1998 | WO1998031798A1 Human extracellular matrix-1 |
| 07/23/1998 | WO1998031796A1 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/23/1998 | WO1998031686A1 Substituted 4-(6-fluoro-(1h)-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of cns-disorders |
| 07/23/1998 | WO1998031680A1 1,4-dihydropyridin derivatives and their use in therapy |
| 07/23/1998 | WO1998031673A1 Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors) |
| 07/23/1998 | WO1998031670A1 Thrombin inhibitors |
| 07/23/1998 | WO1998031660A1 Process for preparing indane-like compounds |
| 07/23/1998 | WO1998031654A1 Aromatic tetracyclic compounds of the retinoid type, method for preparing and use |
| 07/23/1998 | WO1998031390A1 Obesity protein formulations |
| 07/23/1998 | WO1998031389A2 Fibronectin binding protein compositions, antibodies thereto, and methods of use |
| 07/23/1998 | WO1998031385A1 Enhancement of hematopoietic cells |
| 07/23/1998 | WO1998031381A1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 07/23/1998 | WO1998031364A1 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
| 07/23/1998 | WO1998031362A1 Use of pramipexole in the treatment of restless legs syndrome |
| 07/23/1998 | WO1998031359A1 Integrin antagonists |
| 07/23/1998 | WO1998031227A1 Novel cannabinoid receptor modulators |
| 07/23/1998 | WO1998022493A3 N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 07/23/1998 | DE19701619A1 Verwendung von Pramipexol zur Behandlung des restless legs syndroms Use of pramipexole in the treatment of restless legs syndrome |
| 07/23/1998 | CA2403927A1 Human extracellular matrix-1 |
| 07/23/1998 | CA2278452A1 Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors) |
| 07/23/1998 | CA2278424A1 Process for preparing indane-like compounds |
| 07/23/1998 | CA2278349A1 I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis |
| 07/23/1998 | CA2278309A1 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
| 07/23/1998 | CA2278307A1 Novel cannabinoid receptor modulators |
| 07/23/1998 | CA2278153A1 Secreted proteins and polynucleotides encoding them |
| 07/23/1998 | CA2278102A1 Therapies involving mutated heat shock transcription factor |
| 07/23/1998 | CA2278055A1 Human extracellular matrix-1 |
| 07/23/1998 | CA2278023A1 Modulators of insulin receptor activity |
| 07/23/1998 | CA2277929A1 Thrombin inhibitors |
| 07/23/1998 | CA2277793A1 Fibronectin binding protein compositions and methods of use |
| 07/23/1998 | CA2277482A1 Enhancement of hematopoietic cells |
| 07/23/1998 | CA2277282A1 Obesity protein formulations |
| 07/23/1998 | CA2277042A1 Aromatic tetracyclic compounds of the retinoid type, method for preparing and use |
| 07/23/1998 | CA2276111A1 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/22/1998 | EP0854187A2 Novel glucose 6-phosphate dehydrogenase gene |
| 07/22/1998 | EP0854186A2 Staphylococcus aureus cell division gene DivIB |
| 07/22/1998 | EP0854146A1 Substituted 4-(6-fluoro-[1H]-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders |
| 07/22/1998 | EP0854145A2 Vitronectin receptor antagonists, their production and their use |
| 07/22/1998 | EP0854140A2 Vitronectin receptor antagonists, their production and their use |
| 07/22/1998 | EP0853681A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
| 07/22/1998 | EP0853673A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
| 07/22/1998 | EP0853667A2 Bone stimulating factor |
| 07/22/1998 | EP0853628A1 Photolabile 8-substituted cyclic nucleotide esters, methods of preparing them and their use |
| 07/22/1998 | EP0853626A1 Substituted phosphinic compounds and their use as pharmaceuticals |
| 07/22/1998 | EP0853618A1 Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n- (aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |